Progress Software's sales fell, but per-share profit and recurring revenue rose. Those mixed results do not clearly change the company's outlook.
The results point in different directions. Sales fell, but per-share profit rose and recurring revenue grew slightly. The report does not show which change matters more, so it does not clearly change the company's outlook.
A court ruled that patent claims were valid and infringed by Liquidia. The ruling creates a setback for the company and its lead product.
A court upheld claims in a patent asserted by United Therapeutics and found Liquidia infringed them. That supports United Therapeutics' patent position.
Corteva's shares fell before the market opened, but the report gives no business reason for the drop. It does not show a change in Corteva's outlook.
NFT Ltd announced a share sale that can leave existing owners with a smaller portion of the company. That is unfavorable for MI shareholders.
Follow Progress Software Corp (PRGS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PRGS